AMELIA CROWLEY: Open Payments
NPI 1144784323 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 33 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,100
Food & beverage: $1,069Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $500 |
| GENZYME CORPORATION | 3 | $174 |
| Madrigal Pharmaceuticals | 2 | $138 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Janssen Biotech, Inc. | 2 | $52 |
| PFIZER INC. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, REZDIFFRA, TREMFYA, VELSIPITY, ENTYVIO, IQIRVO.
Industry payments across SC — which companies pay providers there.
